Article
The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.
Oncogene - 2 Feb 1995
Huen D S, Henderson S A, Croom-Carter D, Rowe M
Abstract excerpt
The Epstein-Barr virus (EBV) encoded latent membrane protein, LMP1, is oncogenic in rodent fibroblasts and is an essential effector protein in EBV-induced growth-transformation of human B lymphocytes. Previous structure-function studies with LMP1 have relied largely on rodent fibroblast transformation as a functional readout, with apparently conflicting results. We have now analysed several LMP1 mutants in...
Topics
- Animals
- Antigens, CD
- Antigens, Viral
- Base Sequence
- Cell Line
- Chlorocebus aethiops
- Herpesvirus 4, Human
- Humans
- Immunophenotyping
- Molecular Sequence Data
- Mutation
